GerosMicro
Financial Marketplace
Investment & Growth Platform
Preparing your investment experience
Initializing platform... 00%
Vir Biotechnology Stock: Fairly Valued After Phase 3 Success? (NASDAQ:VIR)
  • seekingalpha.com
  • Posted On 10 November 2026

Vir Biotechnology Stock: Fairly Valued After Phase 3 Success? (NASDAQ:VIR)

About six months ago, I wrote an article on Vir Biotechnology, Inc. ( VIR ) following their massive $1.7 billion collaboration agreement with Astellas Pharma. M...
Source: seekingalpha.com
Share Now

Live Support

We're here to help

CUSTOMER SUPPORT

Hello! How can we help you?

Send us a message and our Protocol Officer will assist you.

Connecting to support...